Alzheimer’s Disease/Dementia News

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging have received a $20.5 million grant from the National Institute on Aging to study astrocytes and their role in Alzheimer’s disease and other forms of dementia.

An Alzheimer's disease-centered storyline in the primetime television drama series “This Is Us” reduced stigma around dementia and prompted family discussions, researchers reported in the Journal of Health Communications.

Older adults with dementia are at greater risk for SARS-CoV-2 infection and death, highlighting the need for close monitoring of these patients, researchers reported in the Journal for Alzheimer’s Disease.

History of stroke was associated with increased odds of cognitive impairment in both non-Hispanic white and Mexican American individuals, researchers reported.

Aptinyx Inc. announced it has completed enrollment in the company’s ongoing phase 2 study of NYX-458, an oral treatment for cognitive impairment associated with Parkinson’s disease and dementia with Lewy bodies.

Alpha Cognition Inc. has announced positive results from a bioequivalence study with Alpha-1062, a proprietary, delayed release oral tablet formulation in development for the treatment of mild to moderate Alzheimer’s disease.

Being overweight was negatively associated with the incidence of dementia in women in Germany, while being underweight was linked to dementia in men, researchers reported in the Journal of Alzheimer’s Disease.

Researchers at Invicro have found evidence supporting cellular stress and bioenergetic abnormalities in patients with early-stage Alzheimer's disease, according to new data published in Science Translational Medicine.

SYNAPS Dx has announced the opening of a new laboratory to support the launch of DISCERN, a minimally invasive diagnostic test to identify Alzheimer’s disease in people with dementia.

Leisure activities, such as reading a book, doing yoga and spending time with family and friends, were associated with a decreased risk for all-cause dementia, Alzheimer's disease and vascular dementia, researchers reported in Neurology.